# FDA Inspection 1095607 - IntelliPharmaCeutics Corp. - June 14, 2019

Source: https://www.keypedia.com/records/fda_inspections/intellipharmaceutics-corp/c33b77c0-b3fa-45f7-ae87-48a3ec032d64
Source feed: FDA_Inspections

> FDA Inspection 1095607 for IntelliPharmaCeutics Corp. on June 14, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1095607
- Company Name: IntelliPharmaCeutics Corp.
- Inspection Date: 2019-06-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1190656 - 2022-09-26](https://www.keypedia.com/records/fda_inspections/intellipharmaceutics-corp/be3a4448-52b0-46c5-a43a-37e128df335a)
- [FDA Inspection 885403 - 2014-05-24](https://www.keypedia.com/records/fda_inspections/intellipharmaceutics-corp/bc81d9a4-70d4-4f48-bcb9-2862e928cc16)
- [FDA Inspection 737274 - 2011-07-23](https://www.keypedia.com/records/fda_inspections/intellipharmaceutics-corp/2297a433-f734-4e2a-bab6-24a32378925b)
- [FDA Inspection 698518 - 2010-11-18](https://www.keypedia.com/records/fda_inspections/intellipharmaceutics-corp/d291354e-811b-499e-be41-64f468bb866b)

Company: https://www.keypedia.com/companies/intellipharmaceutics-corp/78f18be2-f4f4-44f4-88d7-30d9f8f36ac5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c